Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Glioblastoma × Drug Therapy × Clear all

Phase

Status

Completed 11 Unknown 2 Terminated 2 Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 CNS 1

Conditions

Breast Neoplasms 6 Head and Neck Neoplasms 5 Carcinoma, Non-Small-Cell Lung 5 Squamous Cell Carcinoma of Head and Neck 3 Neoplasms 3 Neoplasm Metastasis 3 Fallopian Tube Neoplasms 3 Colorectal Neoplasms 3 Anus Neoplasms 3 Urinary Bladder Neoplasms 2 Triple Negative Breast Neoplasms 2 Stomach Neoplasms 2 Prostatic Neoplasms 2 Pancreatic Neoplasms 2 Ovarian Neoplasms 2 Lung Neoplasms 2 Esophageal Squamous Cell Carcinoma 2 Esophageal Neoplasms 2 Carcinoma, Ovarian Epithelial 2 Small Cell Lung Carcinoma 1 Skin Neoplasms 1 Select Advanced Solid Tumors 1 SCLC 1 Rectal Neoplasms 1 Radiation Therapy 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pleural Effusion, Malignant 1 Pain 1 Oropharyngeal Neoplasms 1 Neuroblastoma 1

Interventions

Temozolomide 37 Radiotherapy 15 Radiation 11 Nivolumab 8 Magnetic Resonance Spectroscopy 8 pembrolizumab 6 Specimen Handling 6 Bevacizumab 5 atezolizumab 4 Lomustine 4 Photons 3 Ipilimumab 3 Diet, Ketogenic 3 Cyclophosphamide 3 trametinib 2 sargramostim 2 poly ICLC 2 pamiparib 2 olaparib 2 niraparib 2 dabrafenib 2 azeliragon 2 Transurethral Resection of Bladder 2 Surveys and Questionnaires 2 Surgical Procedures, Operative 2 Standard of Care 2 Receptors, Interleukin-8B 2 Radiotherapy, Intensity-Modulated 2 Radiosurgery 2 OKN 007 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04528680 2025-07-31

SC9/ABX

Northwestern University

Phase 1/2 Active not recruiting

Glioblastoma, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡